John R. Gibson - Concepedia

Author

John R. Gibson

Also Known As

F C Jansen, Gibson J., J Gibson, J R Gibson, J. Gibson, J. R. GIBSON, J. R. GIBSON*, J. R. Gibson, J. Raymond Gibson, J.R. GIBSON

165

Publications

4.8K

Citations

H-Index

145

Concepts

All Affiliations

University of Liverpool Royal London Hospital Wellcome Trust

About

John R. Gibson is an author at University of Liverpool specializing in medicine, dermatology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	42	2.2K
2	Engineering	12	13	422
3	Health Sciences	5	5	351
4	Natural Sciences	5	5	78
5	Education	3	3	101

John R. Gibson

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines Jean Carruthers, Nicholas J. Lowe, Alan Menter, Journal of the American Academy of Dermatology Microbial ToxinGlabellar LinesPathologyPlacebo-controlled StudyDermatology	2002	427
The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease John Steer, John R. Gibson, Stephen C Bourke Thorax	2012	383
Botulinum Toxin Type A (BOTOX <sup>®</sup> ) for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double‐Blind, Placebo‐Controlled Trial Ninan T. Mathew, Benjamin Frishberg, Marek Gawel, Headache The Journal of Head and Face Pain	2005	263
Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Botulinum Toxin Type A for Patients with Glabellar Lines Jean Carruthers, Nicolas J. Lowe, Alan Menter, Plastic & Reconstructive Surgery	2003	230
Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect Gerald D. Weinstein, Gerald G. Krueger, Nicholas J. Lowe, Journal of the American Academy of Dermatology Tazarotene GelTherapeutic EffectOphthalmologyMedicineTopical Drug	1997	186
Nonadiabatic coupling reduces the activation energy in thermally activated delayed fluorescence John R. Gibson, Thomas J. Penfold Physical Chemistry Chemical Physics	2017	161
Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks Gerald D. Weinstein, John Koo, Gerald G. Krueger, Journal of the American Academy of Dermatology Tazarotene Creams 0.05MedicinePsoriatic ArthritisClinical DermatologyTazarotene Cream	2003	135
Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis Mark Lebwohl, Debra Breneman, Bernard S. Goffe, Journal of the American Academy of Dermatology Corticosteroid CreamMedicinePsoriatic ArthritisPlaque PsoriasisClinical Dermatology	1998	135
Tazarotene Cream for the Treatment of Facial Photodamage Sewon Kang, Nicholas J. Lowe, J.‐P. Ortonne, Archives of Dermatology	2001	112
Comparative Study of Antiseptic Toxicity on Basal Keratinocytes, Transformed Human Keratinocytes and Fibroblasts F.M. Tatnall, Irene M. Leigh, John R. Gibson Skin Pharmacology and Physiology	1990	103

Page 1